ES2014060A6 - Pharmaceutical compositions acting on the heart and cardiovascular system - Google Patents

Pharmaceutical compositions acting on the heart and cardiovascular system

Info

Publication number
ES2014060A6
ES2014060A6 ES8901022A ES8901022A ES2014060A6 ES 2014060 A6 ES2014060 A6 ES 2014060A6 ES 8901022 A ES8901022 A ES 8901022A ES 8901022 A ES8901022 A ES 8901022A ES 2014060 A6 ES2014060 A6 ES 2014060A6
Authority
ES
Spain
Prior art keywords
heart
pharmaceutical compositions
cardiovascular system
compositions acting
optionally
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES8901022A
Other languages
Spanish (es)
Inventor
Nagy Peter Literati
Nacida Hegeus Erzsebet Radvany
Maria Boros
Jeno Szilbereky
Gyorgy Blasko
Bela Gachalyi
Nacida Nemes Gizella Hamar
Gabor Nemeth
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BIOREX KFT
Original Assignee
BIOREX KFT
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BIOREX KFT filed Critical BIOREX KFT
Publication of ES2014060A6 publication Critical patent/ES2014060A6/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A61K36/064—Saccharomycetales, e.g. baker's yeast
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Abstract

The compositions comprise 0.5 to 50% by mass of a selenium-containing microorganism and 99.5 to 50% by mass of C18-24 fatty acids containing at least two unsaturated bonds or the derivatives thereof, optionally in admixture with carriers and/or additives commonly used in the pharmaceutical industry and optionally with antioxidants.
ES8901022A 1988-03-23 1989-03-21 Pharmaceutical compositions acting on the heart and cardiovascular system Expired - Fee Related ES2014060A6 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU881484A HU210122B (en) 1988-03-23 1988-03-23 Process for production of composition against thromboembolytic conditions of circulating system and heart

Publications (1)

Publication Number Publication Date
ES2014060A6 true ES2014060A6 (en) 1990-06-16

Family

ID=10954680

Family Applications (1)

Application Number Title Priority Date Filing Date
ES8901022A Expired - Fee Related ES2014060A6 (en) 1988-03-23 1989-03-21 Pharmaceutical compositions acting on the heart and cardiovascular system

Country Status (15)

Country Link
JP (1) JPH0222228A (en)
KR (1) KR890014104A (en)
BE (1) BE1003021A3 (en)
CA (1) CA1319607C (en)
CH (1) CH677732A5 (en)
DE (1) DE3909707A1 (en)
ES (1) ES2014060A6 (en)
FI (1) FI891438A (en)
FR (1) FR2628972B1 (en)
GB (1) GB2216421A (en)
HU (1) HU210122B (en)
IT (1) IT1229205B (en)
LU (1) LU87488A1 (en)
NL (1) NL8900742A (en)
SE (1) SE8901041L (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3114198B2 (en) * 1990-11-06 2000-12-04 ソニー株式会社 Electronics
KR19990015198A (en) * 1997-08-02 1999-03-05 손남율 Vegetable antibiotics
US7608640B2 (en) 1999-03-02 2009-10-27 Jallal Messadek Glycine betaine and its use
BE1012495A3 (en) 1999-03-02 2000-11-07 Messadek Jallal Glycine betaine-for its use antithrombotic.
GB2363331B (en) * 2000-06-17 2003-02-05 Raymond Clifford Noble Supplement to enhance fertility
FR2816211B1 (en) * 2000-11-08 2005-04-01 Brif NEW DIETETIC AND / OR COSMETIC COMPOSITIONS FOR IMPROVING MUCOUS DROUGHT
BE1015608A6 (en) 2003-07-15 2005-06-07 Messadek Jallal TREATMENT arteritis.
US8729124B2 (en) 2002-03-05 2014-05-20 Pronova Biopharma Norge As Use of EPA and DHA in secondary prevention
NZ548508A (en) * 2002-05-03 2008-04-30 Pronova Biocare As Use of EPA and DHA in preventing cerebral damage wherein the dosage ranges from 0.5 to 5.0g of EPA and/or DHA daily
US20040076695A1 (en) 2002-07-08 2004-04-22 Advanced Vision Research EPA and DHA enriched omega-3 supplement for the treatment of dry eye, meibomianitis and xerostomia
US20060233863A1 (en) 2003-02-10 2006-10-19 Enzymotec Ltd. Oils enriched with diacylglycerols and phytosterol esters and unit dosage forms thereof for use in therapy
FR2863170A1 (en) * 2003-12-08 2005-06-10 Nicolai Christian Paul Xavier Composition for regulation and cellular regeneration in the digestive tract, useful e.g. for treating gastroenteritis or improving animal performance, comprises essential oils, shark liver oil, selenium and water
JP2008509213A (en) * 2004-08-09 2008-03-27 エンジモテック リミテッド Food products for diabetics
KR101323513B1 (en) 2004-08-10 2013-10-29 엔지모테크 리미티드 Mixture of Phytosterol Ester(s) and 1,3-Diglyceride(s) for Use in the Treatment of Medical Conditions
WO2006050581A2 (en) 2004-11-10 2006-05-18 Jallal Messadek Betaine as agent against arthropod - or mosquito -borne diseases
HU227588B1 (en) * 2004-12-03 2011-09-28 Sinnex Mueszaki Fejlesztoe Es Tanacsado Kft Antiviral and immunostimulant pharmaceutical composition containing polyunsaturated fatty acid esters
EP2242489A1 (en) 2005-02-15 2010-10-27 Jallal Messadek Combination therapeutic compositions and method of use
BRPI0610249A2 (en) 2005-04-27 2010-06-08 Jallal Messadek pharmaceutical combination or combination, pharmaceutical composition, co-crystallization process and the use of insulin or insulin analogue
ITMI20052483A1 (en) * 2005-12-23 2007-06-24 Novamont Spa BIODEGRADABLE LURES
FR2935394B1 (en) 2008-08-29 2013-03-08 Eco Solution ORGANIC SELENIUM-ENRICHED PHOTOSYNTHETIC MICROORGANISMS FROM SELENO-HYDROXYACID COMPOUNDS AND THEIR USE IN NUTRITION, COSMETICS AND PHARMACY
FR2935393B1 (en) 2008-08-29 2012-08-24 Tetrahedron ORGANIC SELENIUM ENRICHED BACTERIA AND YEASTS FROM SELENO-HYDROXYACID COMPOUNDS AND THEIR NUTRITION, COSMETIC AND PHARMACY APPLICATIONS

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1239587A (en) * 1983-10-24 1988-07-26 David Rubin Combined fatty acid composition for lowering blood cholestrol and triglyceride levels
HU204199B (en) * 1987-03-18 1991-12-30 Caola Kozmetikai Process for producing pharmaceutical compositions containing unsaturated fatty acids and selenium as active components
HU202088B (en) * 1987-03-18 1991-02-28 Caola Kozmetikai Method for producing dietetic preparation
HU209973B (en) * 1988-03-09 1995-01-30 Biorex Kutato Fejlesztoe Kft Process for production of antiviral and immunstimular pharmaceutical composition

Also Published As

Publication number Publication date
IT1229205B (en) 1991-07-25
IT8919876A0 (en) 1989-03-23
FR2628972B1 (en) 1994-09-23
CH677732A5 (en) 1991-06-28
CA1319607C (en) 1993-06-29
HU210122B (en) 1995-02-28
FI891438A (en) 1989-09-24
LU87488A1 (en) 1990-10-02
FR2628972A1 (en) 1989-09-29
KR890014104A (en) 1989-10-21
DE3909707A1 (en) 1989-10-05
JPH0222228A (en) 1990-01-25
FI891438A0 (en) 1989-03-23
NL8900742A (en) 1989-10-16
SE8901041L (en) 1989-09-24
GB2216421A (en) 1989-10-11
SE8901041D0 (en) 1989-03-23
GB8906856D0 (en) 1989-05-10
BE1003021A3 (en) 1991-10-29
HUT60436A (en) 1992-09-28

Similar Documents

Publication Publication Date Title
ES2014060A6 (en) Pharmaceutical compositions acting on the heart and cardiovascular system
AU586892B2 (en) Pharmaceutical and dietary composition
DE3272373D1 (en) Long-chain alpha, omega-dicarboxylic acids and derivatives thereof and pharmaceutical compositions containing them
HK37694A (en) Fatty acids compositions
EP0334507A3 (en) Skin improving composition containing gamma-linolenic acid or dihomo-gamma-linolenic acid
AU1821888A (en) Treatment or prevention of memory loss using essential fatty acid compositions
DE3571200D1 (en) Use of copper and fatty acids
IL71546A (en) Antiprotozoal potentiating compositions comprising 1,4-naphthoquinones in combination with 4-pyridinols
NZ231353A (en) Pharmaceutical compositions comprising 3,5-dihydroxy-7-(1-acyloxyhexahydronaphth-8-yl)-heptanoic acid and lactone derivatives
GB8607137D0 (en) Compositions
ES2009569A6 (en) Compositions acting on the heart and cardio-vascular system
IE842424L (en) Topical preparations containing tar and fatty acids
AU554413B2 (en) Linoleic acid and essential fatty acid compositions as
ES2009248A6 (en) Dietary composition
ES2009249A6 (en) Skin-regenerating cosmetic composition
AU560756B2 (en) Composition containing an essential fatty acid and brotin
NZ218614A (en) 16,17-butylidenedioxy-6,9-difluoro-11-hydroxy-3, 20-dioxopregna-1,4-diene-21-oic acid esters and pharmaceutical compositions
BG52067B2 (en) Antihypoxic and brain-protection antidote composition
ES2004685A6 (en) Hair cosmetic compsn.
ES8609351A1 (en) Hydrosoluble antibiotic pharmaceutical compositions

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19990405